Tenaya Therapeutics Stock Quote TNYA - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.52

Bid

3.11

Ask

3.66

Volume

271,151

3.46 Day's Range 3.585

1.66 52 Week Range 7.01

Market Cap

275.597M

Previous Close

3.51

Open

3.53

Last Trade

3.66

Last Trade Time

Financial Volume

$ 956,619

VWAP

3.528

Average Volume (3m)

338,696

Shares Outstanding

78,517,534

Dividend Yield

PE Ratio

-2.22

Earnings Per Share (EPS)

-1.58

Revenue

Net Profit

-124.08M

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and p... Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.tenayatherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Tenaya Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TNYA. The last closing price for Tenaya Therapeutics was $3.51. Over the last year, Tenaya Therapeutics shares have traded in a share price range of $ 1.66 to $ 7.01.

Tenaya Therapeutics currently has 78,517,534 shares outstanding. The market capitalization of Tenaya Therapeutics is $275.60 million. Tenaya Therapeutics has a price to earnings ratio (PE ratio) of -2.22.

Tenaya Therapeutics Announces Research Leadership Updates

Kathy Ivey, Ph.D., Promoted to Senior Vice President, Research and Timothy Hoey, Ph.D., Transitions to Advisory Role Pediatric Cardiologist and Genetic Therapy Expert Barry J. Byrne, M.D., Ph.D...

Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit

SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Initial Data from Ongoing MyPEAK™-1 Phase 1b of TN-201 Expected in Second Half of 2024 Clinical Sites Activated for RIDGE™-1 Phase 1b Clinical Trial of TN-401 Announced Cost Containment Measures...

Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting

SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Initial Data from Ongoing MyPeak™-1 Phase 1b of TN-201 for MYBPC3-associated HCM Expected in Second Half of 2024 On Track to Dose First Patient in RIDGE™-1Phase 1b Clinical Trial of TN-401 for...

Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine

TN-401 AAV9-Based Gene Therapy Being Developed to Treat the Underlying Cause of PKP2-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) PKP2 Gene Replacement Therapy Normalized...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.64	22.2222222222	2.88	3.6727	2.88	438291	3.15013413	CS
4	0.12	3.52941176471	3.4	3.6727	2.58	461773	3.04214017	CS
12	-0.81	-18.7066974596	4.33	4.96	2.58	338696	3.71711416	CS
26	0.49	16.1716171617	3.03	7.01	2.58	482106	4.63486969	CS
52	-2.02	-36.4620938628	5.54	7.01	1.66	414243	3.91854084	CS
156	-15.98	-81.9487179487	19.5	32	1.64	320698	6.06911202	CS
260	-15.98	-81.9487179487	19.5	32	1.64	320698	6.06911202	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AMIXAutonomix Medical Inc	$ 1.3701 (121.70%)	154.81M
SHOTWSafety Shot Inc	$ 0.41 (115.79%)	7.56k
DATSDatChat Inc	$ 1.89 (81.73%)	54.75M
CYNCYNGN Inc	$ 9.18 (53.77%)	17.79M
SCNIScinai Immunotherapeutics Ltd	$ 5.80 (42.86%)	29.37M
ASLNASLAN Pharmaceuticals Ltd	$ 1.36 (-46.67%)	1.16M
KZIAKazia Therapeutics Ltd	$ 0.5593 (-37.56%)	15.34M
LCFYLocafy Ltd	$ 3.5597 (-36.32%)	584.38k
NAASNaaS Technology Inc	$ 2.82 (-33.02%)	1.94M
ZENVZenvia Inc	$ 1.67 (-26.75%)	658.26k
FFIEFaraday Future Intelligent Electric Inc	$ 0.5152 (22.09%)	217.92M
NVDANVIDIA Corporation	$ 128.44 (-0.62%)	208.32M
SQQQProShares UltraPro Short QQQ	$ 7.46 (-0.67%)	155.14M
AMIXAutonomix Medical Inc	$ 1.3701 (121.70%)	154.81M
TSLATesla Inc	$ 252.64 (1.78%)	147.31M